TRUEX PAUL F 4
4 · Anthera Pharmaceuticals Inc · Filed Sep 7, 2017
Insider Transaction Report
Form 4
TRUEX PAUL F
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2017-09-07$1.34/sh+5,000$6,700→ 16,793 total(indirect: By Trust)
Footnotes (1)
- [F1]The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017.